SINGAPORE – Media Outreach Newswire – 23 September 2024 – Pentair (the “Company”), a leading global water solutions purveyor, is excited to announce its participation in the upcoming FHA-HoReCa 2024 in Singapore from October 22-25. Pentair’s booth number is 4D1-01, located at the entrance of Hall 4. At the event, Pentair will showcase its latest innovations in water filtration technologies, including solutions to address the growing concern over PFAS (per- and polyfluoroalkyl substances), known as “forever chemicals”.
Pentair to unveil its two captivating new technology
The first offering is the advanced PFAS Filter Cartridges, which leverages cutting-edge filtration media that has been certified to reduce up to 99.8% of PFOA/PFOS (part of a large group of lab-made chemicals known as PFAS), chlorine, taste and odor, microplastics, and particulates as small as 0.5 microns in size by mechanical means. This specialized filtration system directly addresses the growing concerns surrounding “forever chemicals” and microplastics in water, ensuring the delivery of safe and fresh drinking water quality. Designed for reliable and long-lasting performance, these filter cartridges can help maintain the optimal operation of water treatment equipment and are suitable for fountain beverages, office coffee service, and low-volume ice machines.
Another star, Pentair’s Everpure MDRO Series uses multi-layer membrane RO filter cartridges to deliver stable and effective water desalination at a large processing capacity of up to 2-4 liters per minute, efficiently handling peak usage while protecting equipment by removing heavy metals, organic compounds, and residual chlorine. By employing advanced RO technology, this filtration system effectively removes a wide range of contaminants, including dissolved salts, minerals, and other impurities, providing users with a consistent supply of high-quality, purified water. It meets Level 1 water efficiency standards, saving water and operating costs.
What is PFAS, and why is it harmful and “forever”?
PFAS, the “forever chemicals”, are a growing concern across many parts of Asia. These synthetic compounds do not easily break down in the environment and can persist for long. They are found in a wide range of everyday products, from non-stick cookware to firefighting foams, and they can easily contaminate water sources when these products are disposed of or used. Prolonged exposure to PFAS has been linked to various adverse health effects, such as reduced fertility, weakened immune systems, weight management issues, and even leading to the development of certain cancers. Given these pollutants’ alarming prevalence and tendency to linger indefinitely in the environment, Pentair’s filtration solutions are engineered to address this challenge, providing customers access to reliable, high-quality water.
Everpure[1] and Manitowoc Ice
In addition to showcasing its latest water filtration technologies, Pentair will highlight the synergies between its Everpure and Manitowoc Ice brands. Acquired by Pentair two years ago, Manitowoc Ice will be featured at the Everpure booth, showcasing its CHOICE ice machines tailored for the Asian market. Likewise, Manitowoc will display Everpure’s filtration systems designed for use with ice machines, demonstrating the close collaboration between these two renowned foodservice brands. This integration will provide hotel, restaurant, and café customers with comprehensive solutions to meet their water quality and ice-making needs in multiple scenarios.
Visitors to the Pentair booth can expect to learn more about the Company’s water purifier, water filter for home, commercial water filtration system, hotel water filtration, and water filter for restaurant solutions, all designed to deliver clean, safe, and great-tasting water.
The issuer is solely responsible for the content of this announcement.
About Pentair
Pentair is a leading global water treatment company committed to delivering innovative, sustainable water solutions that help people, businesses, and industries thrive. With a focus on innovation and a dedication to advancing water quality, Pentair offers a wide range of products and services for residential, commercial, and industrial applications.
FHA-HoReCa 2024 is the leading hospitality trade show in Singapore. Evolved from the highly successful Food&HotelAsia (FHA), FHA-HoReCa brings together the most extensive line-up of leading global suppliers in Asia, showcasing the latest innovations and intelligent technologies catered to the region’s fast-growing foodservice & hospitality industry.
KEELUNG, TAIWAN – Media OutReach Newswire – 23 September 2024 – The Keelung City Culture and Tourism Bureau has announced its participation in the upcoming and highly prestigious “Tourism EXPO Japan” from Sep 26 to 29. With a dedicated booth, the bureau aims to introduce Keelung as a new travel destination in Taiwan for Japanese tourists. Visitors to the Keelung booth can engage in surveys and virtual reality experiences, with the opportunity to receive unique and practical souvenirs that embody the spirit of Keelung. The Bureau invites everyone to explore this beautiful coastal city at the Keelung booth.
Keelung Maritime Plaza
This year, Keelung has earned accolades from the globally acclaimed Harper’s Bazaar as one of the “12 Must-Visit Cities Around the World”. Featured attractions include the Heping Island Geopark, celebrated among the world’s top 21 sunrise locations, and historic sites like the Qing’an Temple. The city’s latest landmark, the Keelung Tower, offers breathtaking and panoramic views of the port and surrounding mountainscape, making Keelung a treasure trove of historical and natural beauty. Japan has always been a key tourism market for Keelung, and the Bureau is eager to introduce this city—hailed as Asia’s best home port for cruise ships—to Japanese travelers. For those who love Taiwanese cuisine, Keelung’s Miaokou Night Market offers a one-stop culinary experience featuring all of Taiwan’s famed street foods, providing a rich and diverse quintessential travel experience in Taiwan.
During the expo period, the Keelung City Culture and Tourism Bureau will distribute various Japanese-language tourism brochures, enhancing visitor engagement and knowledge about Keelung. The Bureau extends a warm invitation to all Japanese tourists to discover the captivating coastal allure of Keelung.
Hashtag: #KeelungCity
The issuer is solely responsible for the content of this announcement.
A Crucial Milestone in the Fight Against Cardiovascular Disease in Chinese Population
HONG KONG SAR – Media OutReach Newswire – 22 September 2024 – A groundbreaking AI-powered risk prediction tool is poised to revolutionize the prevention and management of cardiovascular disease (CVD) within the Chinese population. Professor Celine Chui Sze-ling, Assistant Professor of the School of Nursing and the School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, will lead the research utilizing the innovative Personalized CARdiovascular DIsease risk Assessment for Chinese (P-CARDIAC) model. This AI-driven tool is specifically designed to predict CVD risk in Chinese individuals. The effectiveness of P-CARDIAC will be evaluated in the HEARTWISE study, focusing on its application in secondary care for cardiovascular patients.
Professor Celine Chui Sze-ling, Assistant Professor of the School of Nursing and the School of Public Health and Professor Yiu Kai-hang, Clinical Professor, Cardiology Division, Department of Medicine from LKS Faculty of Medicine, The University of Hong Kong, shared the current status of cardiovascular and cerebrovascular diseases in Hong Kong. They also introduced the P-CARDIAC model and the findings from the HEARTWISE study, which aim to fundamentally change the prevention and management of these diseases among the Chinese population.
A Critical Challenge: CVD in Hong Kong and Beyond Professor Yiu Kai-hang, Clinical Professor, Cardiology Division, Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, states, “Cardiovascular disease remains a leading cause of death globally, claiming an estimated 20.5 million lives annually. The burden of CVD is particularly pronounced in Asia, where 58% of these deaths occur. In Hong Kong, cardiac and cerebrovascular diseases consistently rank among the top five causes of death, highlighting the urgent need for effective prevention and management strategies.”
A Personalized Approach to CVD Prevention P-CARDIAC, developed by a team of multidisciplinary researchers at The University of Hong Kong, is a game-changer in cardiovascular disease (CVD) risk assessment. This AI-powered tool, trained on a vast dataset of patient records from the Hong Kong Hospital Authority, incorporates over 120 risk factors to provide personalized risk scores for each patient. By considering their unique characteristics and medical history, P-CARDIAC offers a comprehensive and nuanced assessment of CVD risk.
HEARTWISE: A Three-Pronged Approach for Combating Cardiovascular Disease Burden The HEARTWISE study, using the P-CARDIAC model, will take a three-pronged approach to investigate the effectiveness of secondary prevention strategies:
Mapping P-CARDIAC Scores with CVD Outcomes: The study will analyze electronic health records and patient-reported symptoms to determine the correlation between P-CARDIAC scores and various factors, including prescriptions and upcoming specialty follow-up appointments. This analysis will help researchers understand how effectively P-CARDIAC predicts actual CVD outcomes and identify potential early warning signs.
Determining P-CARDIAC Risk Thresholds: The study will compare P-CARDIAC scores with clinical judgments from healthcare professionals to establish clear risk thresholds for different levels of CVD risk. This will help provide a more accurate and convenient reference to the healthcare professionals and enable the development of tailored management protocols for patients based on their individual risk profiles.
Comparing CVD Outcomes between Standard Care and Pharmacist-led Services: The study will compare the CVD outcomes of patients receiving standard care with those who receive pharmacist-led services, the latter includes long-term medication management and follow-up provided to patients by pharmacists, working collaboratively within an interdisciplinary team consisting of cardiologists, nurses, and pharmacists. This will assess the potential benefits of pharmacist-led interventions in improving CVD outcomes.
A Collaborative Effort for a Healthier Future The HEARTWISE study, which involves collaboration among researchers, healthcare professionals, and community partners, will recruit over 3,000 patients from six public hospitals across Hong Kong (including Queen Mary Hospital, Queen Elizabeth Hospital, Kwong Wah Hospital, Princess Margaret Hospital, Tuen Mun Hospital, and Pok Oi Hospital) beginning in the fourth quarter of 2024. This initiative, expected to last about two years, aims to generate a robust dataset for comprehensive analysis.
Professor Celine Chui emphasizes, “HEARTWISE represents a significant step forward in our understanding of CVD prevention and management in Chinese populations. By leveraging the power of P-CARDIAC and a multidisciplinary approach, we aim to identify effective strategies for reducing the burden of CVD in Hong Kong and beyond.”
Beyond Hong Kong: A Global Impact HEARTWISE, a groundbreaking study led by The University of Hong Kong, is poised to revolutionize cardiovascular disease (CVD) prevention and management in Chinese populations.
“By leveraging P-CARDIAC’s personalized risk assessment capabilities and a multidisciplinary approach, HEARTWISE aims to identify effective strategies for reducing the burden of CVD in Hong Kong and beyond. The ultimate goal is to incorporate P-CARDIAC into routine clinical practice, leading to improved cardiovascular health outcomes for millions.” commented by Professor Yiu Kai-hang.
This study will have a significant impact on multiple stakeholders, including patients, caregivers, healthcare providers, and payers. The findings have the potential to improve CVD risk assessment, enhance primary and secondary prevention strategies, promote personalized healthcare, explore the benefits of pharmacist-led services, and inform public health policy aimed at reducing the incidence and impact of CVD in Hong Kong and other Asian populations.
Pilot Study: P-CARDIAC Application in District Health Centre Setting In addition to the HEARTWISE study, which focuses on secondary care for cardiovascular disease, a pilot study has been launched in a primary care setting in collaboration with the Hong Kong Society of Rehabilitation (HKSR) at the District Health Centre and a community pharmacy.
The aim of the pilot study is to enhance medication adherence and reduce cardiovascular disease (CVD) risk among patients. This initiative, conducted in collaboration with DHC/E in the Central Western District, a community pharmacy and the Cardiology Outpatient Clinic at Queen Mary Hospital, utilizes the innovative P-CARDIAC model developed by The University of Hong Kong. The primary objective is to empower patients with chronic conditions, such as stroke, post-acute myocardial infarction (Post-AMI), diabetes, and hypertension, by providing targeted medication education and support to improve their self-management skills.
Preliminary results indicate that over 90% of patients experienced a change in their P-CARDIAC score by the second visit, two months after the first. Of the 20 recruited patients, 15 had follow-up visits, and 80% reported an improved understanding of their CVD risk, which contributed to improve better health outcomes and enhanced medication utilization.
This initiative highlights the crucial role of pharmacists in managing CVD risk through a multidisciplinary, patient-centered care approach. By using P-CARDIAC, pharmacists can address barriers to medication adherence and motivate patients to visualize the benefits of their treatments. With a goal to train 10 volunteers and benefit 100 patients annually, the pilot study represents a significant step towards enhancing community-based healthcare services in the region, ultimately alleviating the healthcare burden and reducing public health costs associated with chronic disease management.
Recruitment for Patients with Cardiovascular Diseases (Limited Spots Available) The University of Hong Kong has developed the city’s first AI-driven risk prediction model for cardiovascular diseases, specifically designed for the Chinese population—referred to as the “Personalized CARdiovascular DIsease risk Assessment for Chinese” (P-CARDIAC) model. This model predicts the risk of patients experiencing cardiovascular events over the next 10 years. The research team is currently recruiting eligible patients to explore the feasibility of implementing P-CARDIAC for managing cardiovascular diseases in public hospitals.
Research Procedure:
The research team will obtain individual clinical data.
This data will be used for P-CARDIAC cardiovascular event risk assessment.
→ This will assist doctors in planning management strategies for cardiovascular diseases.
Eligibility Criteria:
Aged 18 to 80 with a history of cardiovascular events (e.g., peripheral artery disease, coronary artery disease, myocardial infarction, stroke, or previous vascular reconstruction surgeries such as bypass or angioplasty).
Under follow-up care in a general medicine or cardiology outpatient clinic.
No cognitive decline, mental illness, or physical disabilities.
For more information about the study, please contact the research team at the University of Hong Kong School of Nursing to inquire and register:
The issuer is solely responsible for the content of this announcement.
About P-CARDIAC and HEARTWISE Study
The P-CARDIAC initiative represents a significant advancement in cardiovascular risk assessment tailored specifically for the Hong Kong population. Developed through a collaborative effort between academic institutions and healthcare partners, P-CARDIAC utilizes machine learning to provide personalized 10-year cardiovascular risk predictions for individuals with established acute coronary syndrome. The HEARTWISE study aims to validate the clinical utility of P-CARDIAC in real-world settings, ensuring that healthcare providers can effectively utilize this tool to enhance patient outcomes. By integrating pharmacist-led services into the management of cardiovascular conditions, HEARTWISE seeks to alleviate the burden on healthcare systems while improving the quality of care for patients.
The P-CARDIAC model represents a significant collaboration among key stakeholders aimed at improving cardiovascular risk assessment in Hong Kong. This initiative is led by principal investigator, Professor Celine Chui Sze-ling, Assistant Professor of the School of Nursing and the School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, and co-principal investigator, Professor Ruibang Luo, Associate Professor of the Department of Computer Science, Faculty of Engineering, The University of Hong Kong.
The development of P-CARDIAC was supported by the Innovation and Technology Fund of the Innovation, Technology and Industry Bureau, with matching fund from Amgen Hong Kong, an international biopharmaceutical company focusing on developing pipeline medicines to address unmet medical needs while leveraging state-of-the-art science to drive solutions that improve health outcomes.
With the use of P-CARDIAC, the HEARTWISE study benefits from the active involvement of six hospitals under the Hong Kong Hospital Authority, which facilitate real-world implementation, data collection and comprehensive data analysis. Together, this study symbolizes a multidisciplinary collaboration to commit advancing innovative and evidence-based strategies to address the rising burden of cardiovascular diseases.
SINGAPORE – Media OutReach Newswire – 20 September 2024 – Luxury Evermore, Singapore’s pre-owned luxury handbag reseller, marks its third anniversary, reflecting on a period of growth and setting sights on future developments. Since its inception in 2021, the company has established itself as a trusted source for authenticated luxury handbags from brands such as Chanel, Dior, and Louis Vuitton.
Strategic Expansion Across Southeast Asia Looking ahead, Luxury Evermore plans to enhance its sourcing network throughout Southeast Asia. By strengthening connections with customers interested in selling their items and fostering relationships with local supply partners, the company aims to expand its collection. This initiative will provide customers with a broader selection of designs and styles from top luxury brands.
“Our goal is to offer an even wider range of luxury handbags to our customers,” said Company Director Carmen Ho. “By improving our sourcing capabilities, we can meet the growing demand and provide more options for those seeking timeless pieces.”
Enhancing Customer Experience Through Digital Platforms In an effort to improve the customer experience, Luxury Evermore is upgrading its digital platforms. Planned enhancements include technical updates and seamless integration between the company’s website and its Telegram community – Luxury Evermore @ Marina Bay. The company is also developing a professional local courier team to offer secure same-day delivery to local customers. Additionally, the customer support team has expanded to provide 24-hour assistance, ensuring prompt responses to inquiries.
“We recognize the importance of convenience and accessibility in today’s market,” Carmen commented. “By investing in our digital infrastructure and customer service, we aim to make the shopping experience as seamless as possible.”
Commitment to Sustainability and Authenticity Luxury Evermore remains dedicated to promoting sustainable luxury by supporting the circular economy. Offering pre-owned handbags allows customers to invest in high-quality pieces while reducing waste. Each item undergoes rigorous authentication and condition checks by in-house specialists, ensuring the originality and quality of every product.
“Sustainability and authenticity are core values for us,” said Carmen. “We believe that luxury should not come at the expense of environmental responsibility, and we are committed to providing genuine products that our customers can trust.”
Vision for the Future With ambitions to become a major player in the luxury resale market across Southeast Asia, Luxury Evermore is poised for continued growth. The company’s focus on expanding its collection, enhancing digital platforms, and improving customer service reflects its commitment to meeting the evolving needs of luxury consumers.
“Our vision is to lead the luxury resale industry in the region,” Carmen stated. “We are excited about the future and will continue to adapt and innovate to serve our customers better.”
The issuer is solely responsible for the content of this announcement.
Luxury Evermore Singapore
Founded in 2021, Luxury Evermore is a Singapore-based reseller specializing in pre-owned luxury handbags. The company offers a curated selection of authenticated products from renowned brands, serving a diverse customer base both locally and internationally. Through its commitment to sustainability, authenticity, and exceptional customer service, Luxury Evermore has established itself as a trusted name in the luxury fashion industry.
LONDON, UK / SINGAPORE – Media OutReach Newswire – 20 September 2024 – The Ascott Limited (Ascott), the Official Global Hotels Partner of Chelsea Football Club, is excited to bring The Famous CFC to Singapore as the event’s presenting partner. This will mark the inaugural Southeast Asian destination for Chelsea’s flagship international fan engagement programme. Scheduled for the weekend of 30 November and 1 December 2024, the two-day visit will be anchored at lyf Funan Singapore, the flagship property of Ascott’s lyf brand that offers an experience-led social living environment in the heart of Singapore’s Civic District.
As the Official Global Hotels Partner of Chelsea Football Club, Ascott is bringing The Famous CFC, Chelsea’s global fan tour to Southeast Asia for the first time, starting with Singapore.
The upcoming Famous CFC in Singapore will feature Chelsea legend Gianfranco Zola, a fan favourite when he played for the Blues from 1996 to 2003. Throughout his career with the Blues, Zola was twice named Player of the Year and was voted by fans as the club’s greatest-ever player in 2003. During his time at Chelsea, he won the UEFA Cup Winners’ Cup, the UEFA Super Cup, two Football Association Challenge Cups, the League Cup and the Community Shield. This event will be Zola’s first visit to Singapore with the Blues.
The Famous CFC is a global fan experience created by Chelsea to strengthen connections with its fans around the world, and to help connect partners and brands within international markets. Introduced in 2023, the event has run two successful editions in Mumbai, India and Los Angeles, USA. The Singapore edition will mark Ascott’s first presentation of The Famous CFC, with plans to introduce it to additional markets in the future.
The Singapore edition of The Famous CFC will be headlined by a watch party at Funan as Chelsea play Aston Villa on 1 December, football coaching clinics delivered by the Chelsea Foundation as well as a meet-and-greet between Zola and local fans, alongside other fan engagement activities. Some of the experiences will be made available exclusively for members of Ascott Star Rewards (ASR).
The Singapore edition of The Famous CFC will be anchored at lyf Funan Singapore, the flagship property of Ascott’s lyf brand
Tan Bee Leng, Chief Commercial Officer, Ascott, said: “Since becoming Chelsea’s Official Global Hotels Partner in July, Ascott has been dedicated to bringing Chelsea fans closer to their beloved football heroes, such as through exclusive hospitality packages at the Ascott Privilege Signatures Stadium Lounge at Stamford Bridge and creative social media content. Recognising that many of Chelsea’s over 600 million fans are based in Southeast Asia, we are thrilled that The Famous CFC is visiting the region very soon. Southeast Asia is one of Ascott’s key markets where we are managing over 360 properties in nine countries. Starting with Singapore, specifically at lyf Funan Singapore as the main venue for The Famous CFC, we hope to build excitement among Chelsea fans ahead of the rebranding of the stadium hotels at Stamford Bridge to lyf by the second half of 2025.”
“The Famous CFC programme seamlessly blends hospitality, entertainment and sports, aligning perfectly with Ascott’s commitment to meeting the growing demand for experiential travel. Through The Famous CFC, we are delighted to offer Chelsea fans unique opportunities to connect with their club and provide exclusive experiences to Ascott Star Rewards members that embody our brand promise of ‘Stay Rewarded’,” she added.
Casper Stylsvig, Chelsea’s Chief Revenue Officer, said: “We are looking forward to bringing The Famous CFC to Singapore in November, and the chance to engage with our passionate fan base of over 60 million people in Southeast Asia.
“It’s the first time we have visited the country since 2017, and we are grateful to Ascott – our presenting partner of this leg of the programme – in sharing our vision of connecting with our fans from across the globe in innovative and exciting ways. We look forward to delivering what will be an unforgettable weekend of activities, for both our supporters and ASR members alike.”
Gianfranco Zola said: “I’m so excited to be involved inThe Famous CFC this year, and to take part in the event for the first time. I know we have a huge fan base in Southeast Asia so it will be really special to spend some time together while exploring a beautiful country.”
Live the Ultimate Chelsea Fan Dream with Ascott Star Rewards In anticipation of The Famous CFC in Singapore, Ascott is pleased to launch an exciting campaign for ASR members. Participants stand to win fantastic prizes including passes to Zola’s meet-and-greet event, signed Chelsea merchandise, tickets to watch Chelsea take on Manchester United live at Stamford Bridge in May 2025 and a stay at an Ascott property using ASR points. For more details on the campaign and prizes, please refer to the Annex and visit https://www.discoverasr.com/en/ascott-chelseafc for updates.
The Famous CFC Experience Packages Ascott has also launched two exclusive experience packages for The Famous CFC in Singapore, available only to ASR members. The ‘Football Fan Experience Package’ for two includes access to a football coaching clinic by the Chelsea Foundation, tickets to the watch party as Chelsea play Aston Villa and a chance to win a Chelsea shirt or football signed by the first team. The higher-tier ‘Ultimate Weekend with Zola Experience Package’ for two includes all the same features, plus an exclusive perk – a VIP meet-and-greet and photo opportunity with Zola. Both packages include ASR points that can used for stays at lyf Funan Singapore or any other participating Ascott property.
About lyf Funan Singapore lyf Funan Singapore is a vibrant hub designed for experience-led social living. With 329 rooms, it is a hotspot for forging connections, featuring trendy shared spaces like open work areas and a modern communal kitchen. It is seamlessly connected to the City Hall MRT interchange via a sheltered underground walkway, providing easy access to all parts of Singapore. As part of the innovative Funan integrated development that also comprises a mall and two office blocks, lyf Funan Singapore is surrounded by modern amenities including trendy dining options, an urban farm, a theatre, a cinema, a gym with a swimming pool, rock climbing walls and a futsal court.
Annex – Book Your Stay with Ascott Star Rewards and Win Exclusive Chelsea Experiences Ready to live the dream of a Chelsea fan? Book your stay with Ascott Star Rewards for a chance to win an exclusive meet-and-greet with Chelsea legend Gianfranco Zola during Famous CFC in Singapore or two tickets to the thrilling Chelsea vs Manchester United match at Stamford Bridge. Every dollar you spend brings you closer to winning!
From London to around the globe, create unforgettable memories that money can’t buy. Enter the draw when you book and stay between 20 September and 13 December 2024.
Book now and let the excitement begin!
First Draw: Score exclusive meet-and-greet with Chelsea legend Gianfranco Zola in Singapore
Prize: A pair of passes to meet the legend in Singapore and signed Chelsea merchandise
Valid book and stay period: 20 September to 10 November 2024
Winner announcement: Week of 11 November 2024
Final Draw: Win a pair of tickets to Chelsea versus Manchester United with a hotel stay in London
Prize: A pair of general admission tickets to watch Chelsea take on Manchester United live at Stamford Bridge in May 2025 (exact match date to be confirmed) and ASR points for a 2D1N stay at one of the ASR participating properties
Valid book and stay period: 20 September to 13 December 2024
The issuer is solely responsible for the content of this announcement.
About Chelsea Football Club
Chelsea Football Club is one of the top football clubs globally and its men’s team were the FIFA Club World Cup winners for 2021, with the final when the side beat Brazilian side Palmeiras in Abu Dhabi held in 2022 due to the pandemic. That success followed winning the UEFA Champions League for a second time in 2021 with victory over Manchester City in Porto.
Founded in 1905, Chelsea is London’s most central football club, based at the iconic 40,000-capacity Stamford Bridge stadium. Nicknamed ‘The Blues’, the club lifted the Champions League for the first time in 2012 and has also won the Premier League five times, the FA Cup eight times, the Football League Cup five times, the UEFA Europa League twice, the UEFA Cup Winners’ Cup twice, the UEFA Super Cup twice and the Football League Championship once, in 1955.
The 2021 Champions League and Super Cup triumphs ensured Chelsea became the first club to win four major UEFA club competitions twice, following its earlier successes in those two competitions as well as the Europa League and Cup Winners’ Cup.
The Chelsea Women’s team have enjoyed a huge amount of success and in 2024 won the FA Women’s Super League for a fifth consecutive year and the seventh time overall. The Women’s FA Cup has been won on five occasions. The side has also captured the FA Women’s League Cup twice as well as reaching the UEFA Women’s Champions League final in 2021.
In addition to possessing some of the world’s most recognisable players, Chelsea has also invested in its future with a state-of-the-art Academy and training centre in Cobham, Surrey. Since the Academy building’s opening in 2008, the club has won seven FA Youth Cups, back-to-back UEFA Youth League titles in 2015 and 2016, and the U23 and U18 Premier League national championships most recently in 2019/20 and 2017/18 respectively.
The Chelsea Foundation boasts one of the most extensive community initiatives in sport, helping to improve the lives of children and young people all over the world.
About The Ascott Limited
Since pioneering Asia Pacific’s first international-class serviced residence with the opening of The Ascott Singapore in 1984, Ascott has grown to be a trusted hospitality company with over 950 properties globally. Headquartered in Singapore, Ascott’s presence extends across more than 230 cities in over 40 countries in Asia Pacific, Central Asia, Europe, the Middle East, Africa, and the USA.
Ascott’s diversified accommodation offerings span serviced residences, coliving properties, hotels and independent senior living apartments, as well as student accommodation and rental housing. Its award-winning hospitality brands include Ascott, Citadines, lyf, Oakwood, Somerset, The Crest Collection, The Unlimited Collection, Fox, Harris, POP!, Preference, Quest, Vertu and Yello. Through Ascott Star Rewards (ASR), Ascott’s loyalty programme, members enjoy exclusive privileges and offers at participating properties.
A wholly owned business unit of CapitaLand Investment Limited, Ascott is a leading vertically-integrated lodging operator. Harnessing its extensive network of third-party owners and in-market expertise, Ascott grows fee-related earnings through its hospitality management and investment management capabilities. Ascott also expands its funds under management by growing its sponsored CapitaLand Ascott Trust and private funds.
This year, Ascott marks 40 years in hospitality service with the launch of Ascott Unlimited, a full year campaign that will offer Unlimited Opportunities, Unlimited Choices, Unlimited Freedom, and Unlimited Good. Navigating a future of unlimited possibilities against a backdrop of global change and evolving perspectives of travel, Ascott Unlimited marks Ascott’s ambitions to break new ground, and springboard to its next chapter of growth as a global hospitality company. Find out more about Ascott Unlimited at www.discoverasr.com/ascottunlimited.
Headquartered and listed in Singapore, CapitaLand Investment Limited (CLI) is a leading global real asset manager with a strong Asia foothold. As at 30 June 2024, CLI had S$134 billion of assets under management, as well as S$100 billion of funds under management held via six listed real estate investment trusts and business trusts and a suite of private real asset vehicles that invest in thematic and tactical strategies. Its diversified real estate asset classes include retail, office, lodging, industrial, logistics, business parks, wellness, self-storage and data centres.
CLI aims to scale its fund management, lodging management and commercial management businesses globally and maintain effective capital management. As the investment management arm of CapitaLand Group, CLI has access to the development capabilities of and pipeline investment opportunities from CapitaLand’s development arm.
As a responsible company, CLI places sustainability at the core of what it does and has committed to achieve Net Zero carbon emissions for Scope 1 and 2 by 2050. CLI contributes to the environmental and social well-being of the communities where it operates, as it delivers long-term economic value to its stakeholders.
The goal is to enhance resilience in facing the effects of climate change on occupational health and safety in schools, homes and workplaces
DUBAI, UNITED ARAB EMIRATES – EQS Newswire – 20 September 2024 – The 26th Water, Energy, Technology and Environment Exhibition (WETEX), organised by Dubai Electricity and Water Authority (DEWA) will take place from 1 to 3 October 2024 at the Dubai World Trade Centre. The event will feature a hub showcasing the latest health and safety technologies and practices to raise the awareness among institutions and individuals on key international standards for health and safety at home and work.
The hub includes four sections: interactive workshops; seminars and panel discussions; children’s safety; and competitions, puzzles, games and raffles to test relevant knowledge and foster innovation in safety procedures.
“WETEX is the largest exhibition of its kind in the region and the most prominent international exhibition specialising in water, energy, sustainability, green technologies, renewable and clean energy, green buildings, electric vehicles, smart grid, and other vital sectors. As such WETEX is committed to expanding its areas of focus and covering all main sectors that ensure a healthier and brighter future for all. Our focus on health and safety this year is in line with our efforts to make the UAE a global leader in the field of quality of life, and to advance well-being, health and quality of life. This supports the Dubai Social Agenda 33, the National Strategy for Wellbeing 2031, and the UN Sustainable Development Goals 2030, including Goal 3: Good Health and Well-being,” said HE Saeed Mohammed Al Tayer, MD & CEO of DEWA, Founder and Chairman of WETEX.
Local and international experts will review guidelines and procedures for occupational safety, physical and mental health, and the latest trends and technologies in this field. They will highlight precautionary measures to avoid accidents and risks, enhance emergency readiness, and manage stress and fatigue. The goal is to enhance resilience in facing the effects of climate change on occupational health and safety in schools, homes and workplaces. The hub will also showcase success stories and initiatives that reinforce companies’ commitment to promoting a safe, healthy work environment, enhancing their reputation as socially responsible institutions.
SINGAPORE – Media OutReach Newswire – 20 September 2024 – Today, NTS proudly opens its new facility in Singapore, merging assembly and manufacturing operations into a state-of-the-art, future-proof production and office space. With this expansion, NTS is fully equipped to be the first-tier contract manufacturer and partner of choice for its clients. The new site in Singapore is set to become an important hub for global clients in the Asian region.
New facility building of NTS Singapore
Vertically integrated solutions for ultraprecision
NTS Singapore specializes in producing complex, mechanic and mechatronic (cleanroom) assemblies that are crucial to the core functionality of its clients’ products. “It was both a necessary and logical step to integrate our assembly and manufacturing processes under one roof,” says Frans van Lierop, Chief Executive Officer of NTS. “As the global demand for ultraprecision components and modules continues to rise, we need to stay ahead. With this new location, we can confidently say we are fully prepared for the future.”
Construction of the new facility began in May 2022, and it has been completed in full compliance with safety regulations and environmental standards. The facility also offers a comfortable and modern working environment for all employees.
Official opening of NTS Singapore , From left to right: Mr. Mathew Ajimon, Operations Director, NTS Singapore ; 2. Ms. Karen Lee, Deputy CEO, ESR-LOGOS REIT ; 3. Mr. Jonas Wintermans, NTS Supervisory Board, NTS Group ; 4. Mr. Roelof Hendriks, Chainman of NTS Supervisory Board, NTS Group ; 5. Mr. Adrian Chui, CEO & Executive Director, ESR-LOGOS REIT ; 6. Mr. Boris Wintermans, NTS Supervisory Board, NTS Group ; 7. Mr. Frans van Lierop, CEO, NTS Group ; 8. Mr. Chris Devillers, Deputy Ambassador, Embassy of the Kingdom of the Netherlands ; 9. Mr. Tan Kong Hwee, EVP & Member of EXCO, Global Enterprises and Marketing, EDB ; 10. Mr. Ed Van Der Sluijs, CFO, NTS Group ; 11. Mr. Soo Haw Yun, Vice President, Global Enterprises, EDB ; 12. Mr. Rogier Niessen, Managing Director, NTS Singapore
The successful completion of this high-profile redevelopment project underscores the strong partnership between NTS and ESR-LOGOS REIT, reflecting a shared commitment to excellence and innovation. Commenting on this milestone, Adrian Chui, Chief Executive Officer and Executive Director of ESR-LOGOS Funds Management, said, “The grand opening of NTS’s new headquarters at 21B Senoko Loop exemplifies our shared commitment to delivering high-quality, tailored solutions that meet the evolving needs of our tenants. We are proud to partner with NTS on this significant project and are excited to support their continued growth and success in the years to come.”
Launching ceremony NTS Singapore opening
Fully operational and ready for the future
“We are proud to say that this new location not only prepares NTS for today’s demands but also equips us to face the challenges and opportunities of tomorrow,” says Niessen. “It allows us to expand our manufacturing footprint and engineering capabilities as NTS in Asia. The site is highly automated, which reduces our reliance on manual labor and increases production efficiency. Additionally, we bring together our expertise, enabling employees to share and expand their knowledge.
This new site allows us to produce solutions with full vertical integration: we offer clients everything from advanced laser welding of critical modules to fully validated complex end integrations, without the need to transport their products. This enables us to produce faster, with higher quality, and at the best possible costs for our clients.”
This new hub demonstrates NTS’s commitment to growth and innovation in partnership with its clients in the semiconductor and analytical market. With the official opening on 20 September, NTS Singapore solidifies its market position. With unparalleled expertise and expanded capacity, they are ready to meet future demand.
The issuer is solely responsible for the content of this announcement.
About NTS
NTS helps accelerate its customers’ innovations. It is a leading first-tier contract manufacturer that develops, manufactures, assembles and tests intricate (opto-) mechatronic systems and mechanical modules. With over 75 years of experience and sites across US, Asia and Europe, NTS is the partner of choice for high tech Original Equipment Manufacturers in the semiconductor and analytical markets. NTS brings together the brightest minds, state-of-the-art facilities and a comprehensive ecosystem, spanning the entire supply chain, to create the most advanced solutions. It is committed to help achieve its customers’ ambitions by ensuring short time-to-market and product leadership.
Some facts:
Headquartered in Eindhoven, the Netherlands
More than 75 years of experience in the manufacturing industry
HONG KONG SAR – Media OutReach Newswire – 20 September 2024 – DL Holdings Group Limited (“DL Holdings” or the “Company“, together with its subsidiaries, the “Group“, Stock Code: 1709.HK) announced that on September 19, 2024, DL Holdings has entered into an acquisition MOU with a Singapore-based wealth management firm (the “Target Company”). The consideration of the Sale Shares is expected to be settled by a combination of cash and allotment and issuance of shares of the Company. The Target Company was based in Singapore and with offices in Dubai, UAE. The preliminary valuation of the Target Company is expected to be approximately US$50 million. The Acquisition will help DL Holdings to expand its footprint in Southeast Asia, explore the Middle East market, and further build a global ecosystem for asset management and investment.
DL Holdings aims to be a prominent asset management and financial services platform. DL Holdings’ current AUM has exceeded US$3.5 billion, with established offices in Shanghai, San Francisco, Singapore, and Japan. The Target Company has an AUM of approximately US$2.6 billion. It has a significant high-net-worth clientele and future growth potential in Singapore and the Middle East. The possible acquisition will create synergies between the two parties in terms of multi-family office and global investments, and will be complementary to the Group’s existing operation and business layout and consolidate its existing advantageous position.
Andy Chen, Chairman of DL Holdings Group, stated, “Over the past decade, DL has established a solid reputation in Hong Kong and the Asia Pacific region. After entering the Hong Kong Stock Connect, we are accelerating the expansion of our global asset allocation and looking for excellent partners. It is believed that this Acquisition will strengthen the Group’s impact in Singapore and expand the Group’s business scope in Singapore and Southeast Asia region by integrating the resources of the target company and building a stronger customer network. In addition, the move will strengthen the foundation for the Group to open up the Middle East marketwith Dubai as the core, and extend westwards into Europe and Africa.”
Established in 2008, the Target Company has accumulated over 400 clients, serving high net worth individuals and institutional investor in India, the Middle East, Switzerland, Africa and Europe. The wealth management company has accumulated extensive experience in providing a full range of multi-family office services and solutions, and its management shares the same vision and objectives as DL Holdings in global asset management and financial services.
Dubai is the economic and commercial center of the Middle East, where East meets West, the gateway to the Middle East and Africa, and an important node of the “One Belt One Road”. With the completion of this Acquisition, DL Holdings Group will take a significant step forward in its multi-family office and global wealth management footprint.
Andy Chen emphasized, “This acquisition would build a close collaboration between our group and the Singapore-based Company which on one hand could provide our group and clients immediate access to the markets in Southeast Asia and the Middle East, while on the other hand giving the Singapore-based Company and its clients access to the markets in HKSAR, Japan and North America, thereby further enhancing the business coverage of both parties and the range of products that could offer to the combined clienteles. On the basis of the solid traditional business of multi-family office, DL has taken the lead in setting up an AI Family Office (DLiFO), which will leverage on the iterative upgrading and mature application of AI to cover and serve more and more clients, with the opportunity to grow the number of clients geometrically, and thus accelerating the achievement of the strategic goal of exceeding US$10 billion in AUM.”
Hashtag: #DLHoldingsGroup #DL #1709HK
The issuer is solely responsible for the content of this announcement.
About DL Holdings Group Limited (Stock Code: 1709.HK)
DL Holdings Group (1709.HK) is a Hong Kong-listed company and has been included in the Stock Connect. DL Holdings Group is a leading asset management and financial service platform in the Asia-Pacific region with focus on family office. The Group is dedicated to providing full-cycle customized wealth management and inheritance services to ultra-high-net-worth families. Additionally, the Group also offers global asset allocation and management services to high-net-worth families, financial institutions, private enterprises and third-party wealth management platforms.
Headquartered in Hong Kong, the Group maintains permanent offices in Shanghai, San Francisco, Singapore and Japan. Committed to aligning with the interests of its clients, DL Holdings delivers customized global family wealth management, private banking and investment banking services. As of 2023, the Group’s AUM has exceeded US$3.5 billion, with nearly US$2.1 billion managed through DL Family Office. The listed company also holds a Singapore RFMC fund license, a Cayman Islands SIBL fund license, and more than 20 Hong Kong Limited Partnership Funds (LPF).